Angiostrongylus cantonensis: Efficacy of albendazole–dexamethasone co-therapy against infection-induced plasminogen activators and eosinophilic meningitis

This publication has 24 references indexed in Scilit:

• Elevation of plasminogen activators in cerebrospinal fluid of mice with eosinophilic meningitis caused by Angiostrongylus cantonensis
  International Journal for Parasitology, 2004
• The efficacy of therapy with albendazole in mice with parasitic meningitis caused by Angiostrongylus cantonensis
  Parasitology Research, 2004
• Combined Treatment with Interleukin-12 and Mebendazole Lessens the Severity of Experimental Eosinophilic Meningitis Caused byAngiostrongylus cantonensisin ICR Mice
  Infection and Immunity, 2003
• Serum Transthyretin Monomer as a Possible Marker of Blood-to-CSF Barrier Disruption
  Journal of Neuroscience, 2003
• Gelatinase B Is Required for Alveolar Bronchiolization after Intratracheal Bleomycin
  The American Journal of Pathology, 2000
• Dexamethasone as Adjunctive Therapy in Bacterial Meningitis
  JAMA, 1997
• Plasma and CSF Levels of Albendazole and Praziquantel in Patients with Neurocysticercosis
  Clinical Neuropharmacology, 1990
• Regulation of human eosinophil precursor production by cytokines: a comparison of recombinant human interleukin-1 (rhIL-1), rhIL-3, rhIL-5, rhIL-6, and rh granulocyte-macrophage colony-stimulating factor
  Blood, 1990
• Recombinant human interleukin 5 is a selective activator of human eosinophil function.
  Journal of Experimental Medicine, 1988
• Biology and Distribution of the Rat Lungworm, Angiostrongylus cantonensis, and its Relationship to Eosinophilic Meningoencephalitis and other Neurological Disorders of Man and Animals
  1965